PAYD · Paid Inc · Executive Compensation
$2.55
At close · Oct 5
Return incl. dividend (before tax)
Going-concern doubt
— cleared Aug 14, 2026
The latest filing states the doubt was alleviated.
“Management believes that the Company has adequate cash resources to fund operations during the next 12 months after the filing of this quarterly report on Form 10-Q. The repayment of the Embolx note receivable will alleviate the concern however the repayment date is uncertain. Additionally, the costs of doing business can be significantly reduced in hopes of eliminating the net loss and continuing to provide positive cash flow from operations.”View the 10-Q filed Aug 14, 2026
Market Cap
$20.35M
Shares
8.48M
Volume · Oct 5
341
Avg daily vol (18 sessions)
824
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
No Compensation Data
No Summary Compensation Table has been imported from this company's proxy statements yet.
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Lance Healy | Director | Appointed | 2026-05-12 |
| David Ogden | Director | Resigned | 2025-10-16 |